Grants8

Grant Information	Key Details	Eligibility & Funding
NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program (RC2 - Clinical Trial Not Allowed) RFA-NS-25-019 Programme: National Institute of Neurological Disorders and Stroke (NINDS)	Core objective: To establish and support programs within academic and research institutions aimed at enhancing research rigor and transparency practices, thereby fostering a culture of high-quality neuroscience research. Target recipients: Academic and research institutions (departments, inter-departmental entities, or equivalent intra-institutional structures). Size: No explicit size limits; programs of variable size, focus, and scope are encouraged. SECTOR-SPECIFIC: Neuroscience research. Geographic scope: United States. Key filtering criteria: Must be an institutional entity with demonstrated involvement in neuroscience research relevant to the NINDS mission. The program must not involve clinical trials. Emphasizes sustainable culture change within the institution. Grant frequency and program context: This is a reissue of a previous funding opportunity (RFA-NS-24-020), indicating a recurring program to address ongoing needs in research quality.	Funding Up to 800000.00 USD Deadline Oct. 17, 2025, 5 p.m.	Details
NIOSH Small Research Grant Program (R03) PAR-18-797 Programme: NIOSH Small Research Grant Program (R03)	This grant, the NIOSH Small Research Grant Program (R03), aims to support small-scale research projects focused on occupational safety and health (OSH). Its core objectives are to understand occupational risks, develop methods to reduce hazards, and translate scientific findings into practical prevention measures. It is SECTOR-SPECIFIC, focusing on areas impacting worker health and safety, guided by the National Occupational Research Agenda (NORA) and NIOSH strategic goals. The target recipients are diverse U.S.-based organizations capable of conducting research, benefiting workers across various industries. The geographic scope is limited to the United States. This is a recurring grant opportunity, part of a larger funding opportunity announcement (FOA) that covers a five-year period.	Funding Up to 100000.00 USD Deadline Nov. 21, 2025, 11:59 p.m.	Details
Bridging historical past and future potential through conservation, preservation, and adaptive use of Europe’s contentious and dissonant heritage 48338233TOPICSen Programme: Horizon Europe	Core objective: To bridge historical past and future potential by conserving, preserving, and adaptively using Europe's contentious and dissonant cultural heritage. Target recipient type and size: Multidisciplinary networks of professionals, including academics, local authorities, cultural and creative industries (CCIs), and researchers. Size is not specified, but consortia are required. SECTOR-SPECIFIC Geographic scope: Europe, with international cooperation encouraged. Legal entities from non-associated third countries may participate exceptionally. Key filtering criteria: Focus on contentious/dissonant heritage, collaborative network, potential for real-world application, policy recommendations. Grant frequency: Part of the Horizon Europe 2025 Work Programme, implying a recurring program, but this specific call is for the 2025 cycle.	Funding Up to 3500000.00 EUR Deadline Sept. 16, 2025, midnight	Details
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed) PAR-23-286 Programme: NIH Research Career Development program	This grant aims to support early-stage postdoctoral researchers in their transition to independent, tenure-track faculty positions, fostering a strong cohort of new, NCI-supported investigators. - Target recipients are individual postdoctoral fellows with research/clinical doctoral degrees. - This is a SECTOR-SPECIFIC grant, focused on cancer research. - Geographic scope is limited to U.S. institutions. - Key filtering criteria include individual's postdoctoral experience (no more than 2 years), lack of prior independent faculty/research positions, and the research not involving leading an independent clinical trial. - This is a recurring grant opportunity with multiple application cycles annually until its expiration.	Funding Up to 249000.00 USD Deadline Oct. 14, 2026, 5 p.m.	Details
Permanently Open Call for Targeted Innovation Projects 4602COMPETITIVE_CALLen Programme: EIT Urban Mobility Business Plan 2023-2025	This is a 'Permanently Open Call for Targeted Innovation Projects' under the EIT Urban Mobility Business Plan 2023-2025. Its core objective is to address strategic gaps in EIT Urban Mobility's innovation portfolio and respond to external changes, such as technological developments, policies, regulations, and urgent events in urban mobility. It is a SECTOR-SPECIFIC grant, focusing exclusively on urban mobility innovation. The grant targets organizations involved in developing solutions for urban transport challenges. While not explicitly stated, the context of EIT Urban Mobility suggests a target for innovators, research institutions, and businesses (including startups, SMEs, and larger enterprises) capable of delivering innovative projects within the urban mobility sector. The geographic scope is primarily European, implied by the 'EIT Urban Mobility' and 'European cycling industry' references. This is a recurring grant opportunity, structured with multiple cut-off dates, each focusing on specific topics. This means the specific focus areas for application may change with each new cut-off.	Funding Up to 200000.00 EUR Deadline Dec. 31, 2025, 5 p.m.	Details
Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required) PAR-25-179 Programme: National Institutes of Health (NIH)	- Single, clear statement of grant's core objective: To support confirmatory efficacy testing of non-pharmacological and selected pharmacological interventions for mental disorders in adults and children, through an experimental therapeutics approach, to provide high scientific utility for 'go/no-go' decisions on further development or dissemination. - Explicit identification of target recipient type and size: Organizations capable of conducting rigorous clinical trials, including academic institutions, non-profits, for-profits (small and large), and various governmental and 'other' entities. No specific size by revenue or employee count is defined, but implies capacity for significant research. - MUST state if grant is 'SECTOR-SPECIFIC' or 'SECTOR-AGNOSTIC': SECTOR-SPECIFIC (Mental Health, Clinical Research, Healthcare, Technology). - Geographic scope and any location requirements: Global; entities from the U.S. and non-U.S. (Foreign Organizations) are eligible. - Key filtering criteria for initial grant screening: Must be a confirmatory efficacy clinical trial (not initial development or pilot testing), must use an experimental therapeutics approach (testing mechanism of action), and must have prior evidence of target engagement and a preliminary efficacy signal. - Grant frequency and program context: Recurring opportunity with multiple application deadlines annually until October 2027; reissued from PAR-21-132, part of NIMH's broader clinical trial development pipeline.	Funding Up to None USD Deadline Oct. 15, 2027, 10 p.m.	Details
Rekrutacja – Kompetentny trener / Na wyższym poziomie – rozwój kompetencji kadr podmiotów świadczących usługi rozwojowe FERS.01.03-IP.09-0054/24 Programme: Fundusze Europejskie dla Rozwoju Społecznego 2021-2027	Core objective: To provide financial support through cost refunds for development services (training and consulting) aimed at enhancing the competencies and qualifications of staff within organizations that offer such services. Target recipient type: Entities registered in the Baza Usług Rozwojowych (Podmiot BUR) and individuals operating sole proprietorships who provide services through Podmiot BURs (Podmiot współpracujący). Target recipient size: All sizes, including SME (Micro, Small, Medium) and ENTERPRISE (Large), with micro and small enterprises receiving preferential points. SECTOR-SPECIFIC/SECTOR-AGNOSTIC: SECTOR-SPECIFIC (specifically targets providers of 'Usługi rozwojowe' / development services, for the purpose of improving their staff's or owner's training, consulting, mentoring, or coaching skills, or new competencies related to their services). Geographic scope: PL (entire Poland). Key filtering criteria for initial grant screening: Must be a Polish entity or sole proprietor involved in providing development services, seeking to upskill their personnel in relevant areas. Must not have received prior support from this specific call. Grant frequency: Recurring, with multiple application rounds until June 2026. Program context: This project is part of the broader 'Fundusze Europejskie dla Rozwoju Społecznego 2021-2027' (European Funds for Social Development 2021-2027) program, under Priority I 'Skills', Action 01.03 'Workforce for a Modern Economy'.	Funding Up to 22400.00 PLN Deadline June 30, 2026, 10 a.m.	Details
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed) PAR-25-118 Programme: National Cancer Institute (NCI)	This funding opportunity, PAR-25-118, from the National Cancer Institute (NCI) aims to support fundamental, mechanistic research into how diet and lipid metabolism are linked to tumor growth and progression. The grant seeks to bridge the fields of nutrition and molecular metabolism, and to stimulate research and tool development in this complex area, especially concerning how lipids connect diet with cancer biology. This is a SECTOR-SPECIFIC grant, focusing specifically on cancer research and nutrition science. It targets a wide range of U.S.-based organizations, from academic institutions to for-profit businesses, involved in biomedical research.	Funding Up to 275000.00 USD Deadline Oct. 23, 2025, 5 p.m.	Details
Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional) RFA-MH-25-205 Programme: National Institute of Mental Health (NIMH) Research Project Grant	This grant, RFA-MH-25-205, aims to deeply understand the bidirectional influences between social media use and adolescent mental health. It supports research into how social media affects mental illness, psychiatric symptoms, and risk/resilience for psychopathology in young people. The grant also seeks proposals that explore how social media can be used to identify adolescents at risk, encourage appropriate mental health service use, and deliver preventive or therapeutic interventions. This opportunity is SECTOR-SPECIFIC, primarily targeting mental health research, social sciences, public health, and technology. The research must focus on adolescents, broadly defined as individuals between 10 and 20 years of age. It is open to organizations in the United States and internationally. This funding opportunity is a reissue of a previous grant, indicating a recurring program.	Funding Up to None USD Deadline Oct. 20, 2025, 5 p.m.	Details
Fast-track Extending U-space eco-system 47761704TOPICSen Programme: Horizon Europe	Grant Purpose and Target Core objective: To significantly advance CNS (Communication, Navigation, Surveillance) capabilities for U-space (unmanned aircraft system airspace) and extend the U-space ecosystem. Explicit identification of target recipient type and size: Any legal entity that can form a consortium (minimum three independent legal entities). SECTOR-SPECIFIC Geographic scope and any location requirements: EU Member States and Horizon Europe Associated Countries. Specific low- and middle-income countries are also eligible for funding if their participation is considered essential or explicitly provided for. Key filtering criteria for initial grant screening: Focus on U-space, CNS, UAS, 5G/cellular networks in aviation. Consortium formation. Strict geographic and political exclusions apply. Grant frequency and program context: This is part of the SESAR 3 Joint Undertaking Bi-Annual Work Programme 2024-2025, indicating a recurring program context.	Funding Up to 5000000.00 EUR Deadline Sept. 16, 2025, midnight	Details
Adapting to and mitigating demographic trends in rural areas through evidence-based planning and innovative solutions HORIZON-CL6-2025-02-COMMUNITIES-01 Programme: Horizon Europe	Adapting to and mitigating demographic trends in rural areas through evidence-based planning and innovative solutions. - Primary objective: Support rural communities in managing population changes, improving well-being, and enhancing attractiveness through sustainable and innovative approaches. - Target recipients: A wide range of organizations and stakeholders involved in rural development, including public authorities, rural communities, SMEs, and social economy actors. - Size: Not specified, open to various organizational sizes given the multi-actor approach. - SECTOR-SPECIFIC focusing on rural communities, demography, and related social, economic, and environmental aspects. - Geographic scope: Primarily EU and Associated Countries, with opportunities for non-EU/non-Associated Countries under specific conditions. - Key filtering criteria: Focus on rural areas, demographic trends, multi-actor collaboration, and innovative/evidence-based solutions. - Grant frequency: Part of the Horizon Europe Work Programme 2025, which is a recurring multi-annual funding framework.	Funding Up to 6500000.00 EUR Deadline Sept. 16, 2025, midnight	Details
Open topic on efficient border surveillance and maritime security HORIZON-CL3-2025-01-BM-01 Programme: Horizon Europe - Civil Security for Society	This grant, an Innovation Action within the Horizon Europe framework, aims to significantly improve the security of EU external borders and maritime environments. It seeks novel and disruptive technological and operational solutions to enhance surveillance, real-time situational awareness, and rapid response capabilities. The core objective is to tackle challenges like illegal trafficking, irregular migration, natural disasters, piracy, and potential terrorist attacks in these critical areas. This is a SECTOR-SPECIFIC grant, primarily targeting organizations involved in civil security, border management, and maritime operations. The specific target recipients are Border or Coast Guard Authorities from EU Member States or Associated Countries, which must be actively involved as beneficiaries. Other security practitioners like Police and Customs Authorities are also welcome to participate. Its geographic scope is focused on EU external borders and maritime surrounding areas, including pre-frontier regions that might be impacted by geopolitical instabilities. This grant is part of an ongoing program within Horizon Europe, suggesting it's a recurring funding area.	Funding Up to 3333333.00 EUR Deadline Nov. 12, 2025, midnight	Details
Risk, robustness and resilience for autonomous vehicles in military operations EDF-2025-LS-RA-SI-CYBER-3RAV-STEP Programme: European Defence Fund (EDF)	Core Objective: To enhance the security and resilience of autonomous vehicles (UxVs) in military operations against cyber threats, contributing to a stronger and more technologically independent European Defence Technological and Industrial Base (EDTIB). Target Recipients: Legal entities, including SMEs and mid-caps, from EU Member States and EDF Associated Countries. SECTOR-SPECIFIC: Defence, Cybersecurity, Autonomous Systems. Geographic Scope: Organisations established in EU Member States and listed EDF Associated Countries. Project activities and infrastructure must be located/held in these countries. Key Filtering Criteria: Must be a legal entity, established in an eligible country, participate in a consortium of at least 3 independent applicants from 3 different eligible countries, and focus on research for autonomous military vehicles' cyber resilience. Grant Frequency: Recurring (part of the annual EDF Work Programme). Program Context: Part of the European Defence Fund (EDF) and contributes to the Strategic Technologies for Europe Platform (STEP) objectives in deep and digital technologies.	Funding Up to 20000000.00 EUR Deadline Oct. 16, 2025, 4 p.m.	Details
Sufficiency measures in the built environment 48350312TOPICSen Programme: Horizon Europe - New European Bauhaus Facility	This grant aims to drive the transformation of the European built environment towards a more sustainable and resource-efficient model. The core objective is to validate and implement 'sufficiency measures' that reduce the demand for new construction and raw materials by optimizing the use of existing spaces, buildings, and infrastructure. It seeks to integrate circular economy principles and improve climate adaptability while considering the well-being of inhabitants. This funding is primarily targeted at organizations and consortia capable of conducting research and innovation activities related to urban planning, architectural design, construction, and sustainable development. Projects must involve real-world testing in multiple locations. This is a SECTOR-SPECIFIC grant, focused on the built environment, construction, and urban development. The geographic scope requires projects to be implemented in at least three distinct neighbourhoods (urban, peri-urban, or rural) located in at least three different EU Member States or Associated Countries. Key filtering criteria for initial screening include a clear focus on sufficiency measures, resource demand reduction in the built environment, a strong research and innovation component, and the ability to conduct multi-country pilot projects. This topic is part of the New European Bauhaus (NEB) initiative within the Horizon Europe Work Programme 2025, indicating it is a recurring program, but this specific call is for the 2025 funding cycle.	Funding Up to 4000000.00 EUR Deadline Nov. 12, 2025, midnight	Details
NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed) PAR-24-301 Programme: National Institutes of Health (NIH)	The core objective of this grant is to support the continued operation, maintenance, and enhancement of mature bioinformatics resources. These resources must be crucial for the research community utilizing animal models of embryonic developmental processes, with an emphasis on wide dissemination and interoperability. - Target recipient type and size: Organizations such as Higher Education Institutions, Nonprofits, For-Profit Organizations, and various Government entities that currently maintain established, mature bioinformatics resources. Organizational size is not defined by employee count, but implies entities with significant scientific and technical capacity. - SECTOR-SPECIFIC: This grant is sector-specific, focusing on bioinformatics resources within biomedical research, particularly developmental biology and congenital anomalies. - Geographic scope and any location requirements: The lead applicant organization must be based in the United States. While foreign components (e.g., international collaborators) are allowed within a U.S. organization's application, non-U.S. entities are not eligible to apply as the primary applicant. - Key filtering criteria for initial grant screening: The project must involve a mature, existing bioinformatics resource, not initial research and development or proof-of-concept. It must pertain to animal models of embryonic developmental processes, human/animal development, or structural congenital anomalies. Clinical trials are not allowed. - Grant frequency and program context: This is a recurring grant opportunity, being a reissue of a previous program (PAR-20-126). It is part of the National Institutes of Health's (NIH) ongoing efforts to support critical bioinformatics infrastructure for large-scale biological data.	Funding Up to 1750000.00 USD Deadline Sept. 25, 2027, 5 p.m.	Details
Fighting against anti-Muslim hatred CERV-2025-EQUAL-ANTIMUSLIM Programme: Citizens, Equality, Rights and Value Programme (CERV)	This grant, titled 'Fighting against anti-Muslim hatred,' is a specific priority within the broader 'Call for proposals to promote equality and to fight against racism, xenophobia and all other forms of discrimination' under the Citizens, Equality, Rights and Value Programme (CERV). Its core objective is to support EU action grants aimed at combating anti-Muslim hatred, discrimination, and racism. It is a SECTOR-SPECIFIC grant, focusing on social issues related to equality and non-discrimination. The exact target recipient type and size, as well as the specific geographic scope and eligible countries, are not detailed in the provided grant information but are referred to external call documents. This grant is part of the recurring CERV program (2021-2027), indicating ongoing opportunities in this area.	Funding Up to None EUR Deadline Oct. 23, 2025, 3 p.m.	Details
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed) PAR-25-154 Programme: NIH HEAL Initiative	The core objective of this grant is to identify new druggable targets for pain within the understudied druggable proteome. It aims to support pilot projects that generate preliminary data and tools for these targets, ultimately contributing to novel medications for pain and the opioid addiction cycle. Explicit identification of target recipient type: This grant targets a broad range of research-focused entities, including higher education institutions, non-profits, for-profit organizations, and various governmental bodies with scientific research capacity. Size: Not explicitly defined by employee count, but the 'R03 Small Grant Program' designation indicates a focus on projects of limited scope and budget. SECTOR-SPECIFIC: This grant is highly sector-specific, focusing on HEALTHCARE, particularly biomedical research, pain management, and opioid addiction. Geographic scope: Applicant organizations must be based in the United States. While foreign components (collaborators) are allowed, the primary applying entity must be U.S.-based. Key filtering criteria for initial grant screening: The project must focus on one or more of the explicitly listed understudied proteins within the NOFO. The project must not involve clinical trials or clinical drug development studies. The research must be related to pain and/or pain management. The applicant organization must be U.S.-based. Grant frequency: This is a recurring funding opportunity, noted as a reissue of a previous program (PAR-24-197). Program context: This grant is part of the broader NIH HEAL Initiative (Helping to End Addiction Long-term), addressing the national opioid public health crisis.	Funding Up to 100000.00 USD Deadline July 16, 2026, 10 p.m.	Details
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) PAR-24-063 Programme: Blueprint Neurotherapeutics Network (BPN)	The core objective of this grant is to advance small molecule drug discovery and development projects, specifically for disorders of the nervous system, towards clinical application. It targets United States small business concerns (SBCs) that have projects in either the Discovery (early-stage optimization) or Development (pre-clinical to Phase I clinical testing) phase. - Single, clear statement of grant's core objective: To facilitate the discovery and development of small molecule neurotherapeutics from pre-clinical stages through Phase I clinical trials by providing funding, resources, and expert support to small business concerns. - Explicit identification of target recipient type and size: Small Business Concerns (SBCs) with not more than 500 employees. - MUST state if grant is 'SECTOR-SPECIFIC' or 'SECTOR-AGNOSTIC': SECTOR-SPECIFIC (Neuroscience, Small Molecule Drug Development). - Geographic scope and any location requirements: Organizations must be located in the United States and operate primarily within the US. - Key filtering criteria for initial grant screening: - Must be a US-based small business concern. - Focus on small molecule drug discovery and development for nervous system disorders. - Project must be in Discovery or Development stage (pre-clinical to Phase I clinical trials). - Projects focusing on biologics, biotechnology products, devices, basic research, or beyond Phase I clinical testing are not eligible. - Grant frequency and program context: This is a reissue (PAR-24-063) and offers recurring application due dates, indicating it is a recurring opportunity within the Blueprint Neurotherapeutics Network (BPN) program.	Funding Up to 5500000.00 USD Deadline July 15, 2026, 5 p.m.	Details
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) PAR-24-098 Programme: Small Business Innovation Research (SBIR) Program	This grant, `PAR-24-098`, aims to support the rigorous analytical validation of methods used for measuring biomarkers relevant to neurological and neuromuscular disorders. The goal is to prepare these biomarkers for use in clinical trials or clinical practice. Target Recipient Type and Size: SME (small business concerns, generally with less than 500 employees). SECTOR-SPECIFIC: Healthcare, specifically neurological and neuromuscular disorders. Geographic Scope: Applicants must be U.S.-based organizations. Key Filtering Criteria: Focus on analytical validation of biomarkers for neurological/neuromuscular disorders, U.S. small business, and experience in biomarker research. Grant Frequency and Program Context: This is a recurring funding opportunity (reissue of `PAR-21-057`) under the NIH Small Business Innovation Research (SBIR) program, designed to bridge the gap between biomarker discovery and clinical application.	Funding Up to 1500000.00 USD Deadline June 22, 2026, 5 p.m.	Details
Partners for Fish and Wildlife Program Partners for Fish and Wildlife Program Programme: U.S. Fish & Wildlife Service	The core objective of the Partners for Fish and Wildlife Program is to provide technical and financial assistance to private landowners for restoring, enhancing, and managing fish and wildlife habitats on their land across the United States. This program aims to conserve and improve wildlife habitat by partnering with a broad range of private entities. - Target recipient type and size: Private landowners, managers, tribes, corporations, schools, non-profits, farmers, ranchers, forest landowners, recreational landowners, local governments, and universities. - SECTOR-SPECIFIC: Environmental conservation, land management, agriculture, and forestry. - Geographic scope: United States (all 50 states and territories). - Key filtering criteria for initial grant screening: Private land ownership, interest in wildlife habitat improvement, willingness to commit to a minimum 10-year project duration. - Grant frequency and program context: This is an ongoing, recurring program established since 1987, reauthorized by the Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025.	Funding Up to 0.00 USD Deadline March 8, 2029, 4:59 a.m.	Details

NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program (RC2 - Clinical Trial Not Allowed)

RFA-NS-25-019

Programme: National Institute of Neurological Disorders and Stroke (NINDS)

Core objective: To establish and support programs within academic and research institutions aimed at enhancing research rigor and transparency practices, thereby fostering a culture of high-quality neuroscience research.
Target recipients: Academic and research institutions (departments, inter-departmental entities, or equivalent intra-institutional structures).
Size: No explicit size limits; programs of variable size, focus, and scope are encouraged.
SECTOR-SPECIFIC: Neuroscience research.
Geographic scope: United States.
Key filtering criteria: Must be an institutional entity with demonstrated involvement in neuroscience research relevant to the NINDS mission. The program must not involve clinical trials. Emphasizes sustainable culture change within the institution.
Grant frequency and program context: This is a reissue of a previous funding opportunity (RFA-NS-24-020), indicating a recurring program to address ongoing needs in research quality.

Funding

Up to 800000.00 USD

Deadline

Oct. 17, 2025, 5 p.m.

Details

NIOSH Small Research Grant Program (R03)

PAR-18-797

Programme: NIOSH Small Research Grant Program (R03)

This grant, the NIOSH Small Research Grant Program (R03), aims to support small-scale research projects focused on occupational safety and health (OSH). Its core objectives are to understand occupational risks, develop methods to reduce hazards, and translate scientific findings into practical prevention measures. It is SECTOR-SPECIFIC, focusing on areas impacting worker health and safety, guided by the National Occupational Research Agenda (NORA) and NIOSH strategic goals. The target recipients are diverse U.S.-based organizations capable of conducting research, benefiting workers across various industries. The geographic scope is limited to the United States. This is a recurring grant opportunity, part of a larger funding opportunity announcement (FOA) that covers a five-year period.

Funding

Up to 100000.00 USD

Deadline

Nov. 21, 2025, 11:59 p.m.

Details

Bridging historical past and future potential through conservation, preservation, and adaptive use of Europe’s contentious and dissonant heritage

48338233TOPICSen

Programme: Horizon Europe

Core objective: To bridge historical past and future potential by conserving, preserving, and adaptively using Europe's contentious and dissonant cultural heritage.
Target recipient type and size: Multidisciplinary networks of professionals, including academics, local authorities, cultural and creative industries (CCIs), and researchers. Size is not specified, but consortia are required.
SECTOR-SPECIFIC
Geographic scope: Europe, with international cooperation encouraged. Legal entities from non-associated third countries may participate exceptionally.
Key filtering criteria: Focus on contentious/dissonant heritage, collaborative network, potential for real-world application, policy recommendations.
Grant frequency: Part of the Horizon Europe 2025 Work Programme, implying a recurring program, but this specific call is for the 2025 cycle.

Funding

Up to 3500000.00 EUR

Deadline

Sept. 16, 2025, midnight

Details

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)

PAR-23-286

Programme: NIH Research Career Development program

This grant aims to support early-stage postdoctoral researchers in their transition to independent, tenure-track faculty positions, fostering a strong cohort of new, NCI-supported investigators. - Target recipients are individual postdoctoral fellows with research/clinical doctoral degrees. - This is a SECTOR-SPECIFIC grant, focused on cancer research. - Geographic scope is limited to U.S. institutions. - Key filtering criteria include individual's postdoctoral experience (no more than 2 years), lack of prior independent faculty/research positions, and the research not involving leading an independent clinical trial. - This is a recurring grant opportunity with multiple application cycles annually until its expiration.

Funding

Up to 249000.00 USD

Deadline

Oct. 14, 2026, 5 p.m.

Details

Permanently Open Call for Targeted Innovation Projects

4602COMPETITIVE_CALLen

Programme: EIT Urban Mobility Business Plan 2023-2025

This is a 'Permanently Open Call for Targeted Innovation Projects' under the EIT Urban Mobility Business Plan 2023-2025. Its core objective is to address strategic gaps in EIT Urban Mobility's innovation portfolio and respond to external changes, such as technological developments, policies, regulations, and urgent events in urban mobility. It is a SECTOR-SPECIFIC grant, focusing exclusively on urban mobility innovation. The grant targets organizations involved in developing solutions for urban transport challenges. While not explicitly stated, the context of EIT Urban Mobility suggests a target for innovators, research institutions, and businesses (including startups, SMEs, and larger enterprises) capable of delivering innovative projects within the urban mobility sector. The geographic scope is primarily European, implied by the 'EIT Urban Mobility' and 'European cycling industry' references. This is a recurring grant opportunity, structured with multiple cut-off dates, each focusing on specific topics. This means the specific focus areas for application may change with each new cut-off.

Funding

Up to 200000.00 EUR

Deadline

Dec. 31, 2025, 5 p.m.

Details

Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)

PAR-25-179

Programme: National Institutes of Health (NIH)

- Single, clear statement of grant's core objective: To support confirmatory efficacy testing of non-pharmacological and selected pharmacological interventions for mental disorders in adults and children, through an experimental therapeutics approach, to provide high scientific utility for 'go/no-go' decisions on further development or dissemination. - Explicit identification of target recipient type and size: Organizations capable of conducting rigorous clinical trials, including academic institutions, non-profits, for-profits (small and large), and various governmental and 'other' entities. No specific size by revenue or employee count is defined, but implies capacity for significant research. - MUST state if grant is 'SECTOR-SPECIFIC' or 'SECTOR-AGNOSTIC': SECTOR-SPECIFIC (Mental Health, Clinical Research, Healthcare, Technology). - Geographic scope and any location requirements: Global; entities from the U.S. and non-U.S. (Foreign Organizations) are eligible. - Key filtering criteria for initial grant screening: Must be a confirmatory efficacy clinical trial (not initial development or pilot testing), must use an experimental therapeutics approach (testing mechanism of action), and must have prior evidence of target engagement and a preliminary efficacy signal. - Grant frequency and program context: Recurring opportunity with multiple application deadlines annually until October 2027; reissued from PAR-21-132, part of NIMH's broader clinical trial development pipeline.

Funding

Up to None USD

Deadline

Oct. 15, 2027, 10 p.m.

Details

Rekrutacja – Kompetentny trener / Na wyższym poziomie – rozwój kompetencji kadr podmiotów świadczących usługi rozwojowe

FERS.01.03-IP.09-0054/24

Programme: Fundusze Europejskie dla Rozwoju Społecznego 2021-2027

Core objective: To provide financial support through cost refunds for development services (training and consulting) aimed at enhancing the competencies and qualifications of staff within organizations that offer such services.
Target recipient type: Entities registered in the Baza Usług Rozwojowych (Podmiot BUR) and individuals operating sole proprietorships who provide services through Podmiot BURs (Podmiot współpracujący).
Target recipient size: All sizes, including SME (Micro, Small, Medium) and ENTERPRISE (Large), with micro and small enterprises receiving preferential points.
SECTOR-SPECIFIC/SECTOR-AGNOSTIC: SECTOR-SPECIFIC (specifically targets providers of 'Usługi rozwojowe' / development services, for the purpose of improving their staff's or owner's training, consulting, mentoring, or coaching skills, or new competencies related to their services).
Geographic scope: PL (entire Poland).
Key filtering criteria for initial grant screening: Must be a Polish entity or sole proprietor involved in providing development services, seeking to upskill their personnel in relevant areas. Must not have received prior support from this specific call.
Grant frequency: Recurring, with multiple application rounds until June 2026.
Program context: This project is part of the broader 'Fundusze Europejskie dla Rozwoju Społecznego 2021-2027' (European Funds for Social Development 2021-2027) program, under Priority I 'Skills', Action 01.03 'Workforce for a Modern Economy'.

Funding

Up to 22400.00 PLN

Deadline

June 30, 2026, 10 a.m.

Details

Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed)

PAR-25-118

Programme: National Cancer Institute (NCI)

This funding opportunity, PAR-25-118, from the National Cancer Institute (NCI) aims to support fundamental, mechanistic research into how diet and lipid metabolism are linked to tumor growth and progression. The grant seeks to bridge the fields of nutrition and molecular metabolism, and to stimulate research and tool development in this complex area, especially concerning how lipids connect diet with cancer biology. This is a SECTOR-SPECIFIC grant, focusing specifically on cancer research and nutrition science. It targets a wide range of U.S.-based organizations, from academic institutions to for-profit businesses, involved in biomedical research.

Funding

Up to 275000.00 USD

Deadline

Oct. 23, 2025, 5 p.m.

Details

Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional)

RFA-MH-25-205

Programme: National Institute of Mental Health (NIMH) Research Project Grant

This grant, RFA-MH-25-205, aims to deeply understand the bidirectional influences between social media use and adolescent mental health. It supports research into how social media affects mental illness, psychiatric symptoms, and risk/resilience for psychopathology in young people. The grant also seeks proposals that explore how social media can be used to identify adolescents at risk, encourage appropriate mental health service use, and deliver preventive or therapeutic interventions. This opportunity is SECTOR-SPECIFIC, primarily targeting mental health research, social sciences, public health, and technology. The research must focus on adolescents, broadly defined as individuals between 10 and 20 years of age. It is open to organizations in the United States and internationally. This funding opportunity is a reissue of a previous grant, indicating a recurring program.

Funding

Up to None USD

Deadline

Oct. 20, 2025, 5 p.m.

Details

Fast-track Extending U-space eco-system

47761704TOPICSen

Programme: Horizon Europe

Grant Purpose and Target

Core objective: To significantly advance CNS (Communication, Navigation, Surveillance) capabilities for U-space (unmanned aircraft system airspace) and extend the U-space ecosystem.
Explicit identification of target recipient type and size: Any legal entity that can form a consortium (minimum three independent legal entities).
SECTOR-SPECIFIC
Geographic scope and any location requirements: EU Member States and Horizon Europe Associated Countries. Specific low- and middle-income countries are also eligible for funding if their participation is considered essential or explicitly provided for.
Key filtering criteria for initial grant screening: Focus on U-space, CNS, UAS, 5G/cellular networks in aviation. Consortium formation. Strict geographic and political exclusions apply.
Grant frequency and program context: This is part of the SESAR 3 Joint Undertaking Bi-Annual Work Programme 2024-2025, indicating a recurring program context.

Funding

Up to 5000000.00 EUR

Deadline

Sept. 16, 2025, midnight

Details

Adapting to and mitigating demographic trends in rural areas through evidence-based planning and innovative solutions

HORIZON-CL6-2025-02-COMMUNITIES-01

Programme: Horizon Europe

Adapting to and mitigating demographic trends in rural areas through evidence-based planning and innovative solutions. - Primary objective: Support rural communities in managing population changes, improving well-being, and enhancing attractiveness through sustainable and innovative approaches. - Target recipients: A wide range of organizations and stakeholders involved in rural development, including public authorities, rural communities, SMEs, and social economy actors. - Size: Not specified, open to various organizational sizes given the multi-actor approach. - SECTOR-SPECIFIC focusing on rural communities, demography, and related social, economic, and environmental aspects. - Geographic scope: Primarily EU and Associated Countries, with opportunities for non-EU/non-Associated Countries under specific conditions. - Key filtering criteria: Focus on rural areas, demographic trends, multi-actor collaboration, and innovative/evidence-based solutions. - Grant frequency: Part of the Horizon Europe Work Programme 2025, which is a recurring multi-annual funding framework.

Funding

Up to 6500000.00 EUR

Deadline

Sept. 16, 2025, midnight

Details

Open topic on efficient border surveillance and maritime security

HORIZON-CL3-2025-01-BM-01

Programme: Horizon Europe - Civil Security for Society

This grant, an Innovation Action within the Horizon Europe framework, aims to significantly improve the security of EU external borders and maritime environments. It seeks novel and disruptive technological and operational solutions to enhance surveillance, real-time situational awareness, and rapid response capabilities. The core objective is to tackle challenges like illegal trafficking, irregular migration, natural disasters, piracy, and potential terrorist attacks in these critical areas. This is a SECTOR-SPECIFIC grant, primarily targeting organizations involved in civil security, border management, and maritime operations. The specific target recipients are Border or Coast Guard Authorities from EU Member States or Associated Countries, which must be actively involved as beneficiaries. Other security practitioners like Police and Customs Authorities are also welcome to participate. Its geographic scope is focused on EU external borders and maritime surrounding areas, including pre-frontier regions that might be impacted by geopolitical instabilities. This grant is part of an ongoing program within Horizon Europe, suggesting it's a recurring funding area.

Funding

Up to 3333333.00 EUR

Deadline

Nov. 12, 2025, midnight

Details

Risk, robustness and resilience for autonomous vehicles in military operations

EDF-2025-LS-RA-SI-CYBER-3RAV-STEP

Programme: European Defence Fund (EDF)

Core Objective: To enhance the security and resilience of autonomous vehicles (UxVs) in military operations against cyber threats, contributing to a stronger and more technologically independent European Defence Technological and Industrial Base (EDTIB).
Target Recipients: Legal entities, including SMEs and mid-caps, from EU Member States and EDF Associated Countries.
SECTOR-SPECIFIC: Defence, Cybersecurity, Autonomous Systems.
Geographic Scope: Organisations established in EU Member States and listed EDF Associated Countries. Project activities and infrastructure must be located/held in these countries.
Key Filtering Criteria: Must be a legal entity, established in an eligible country, participate in a consortium of at least 3 independent applicants from 3 different eligible countries, and focus on research for autonomous military vehicles' cyber resilience.
Grant Frequency: Recurring (part of the annual EDF Work Programme).
Program Context: Part of the European Defence Fund (EDF) and contributes to the Strategic Technologies for Europe Platform (STEP) objectives in deep and digital technologies.

Funding

Up to 20000000.00 EUR

Deadline

Oct. 16, 2025, 4 p.m.

Details

Sufficiency measures in the built environment

48350312TOPICSen

Programme: Horizon Europe - New European Bauhaus Facility

This grant aims to drive the transformation of the European built environment towards a more sustainable and resource-efficient model. The core objective is to validate and implement 'sufficiency measures' that reduce the demand for new construction and raw materials by optimizing the use of existing spaces, buildings, and infrastructure. It seeks to integrate circular economy principles and improve climate adaptability while considering the well-being of inhabitants. This funding is primarily targeted at organizations and consortia capable of conducting research and innovation activities related to urban planning, architectural design, construction, and sustainable development. Projects must involve real-world testing in multiple locations. This is a SECTOR-SPECIFIC grant, focused on the built environment, construction, and urban development. The geographic scope requires projects to be implemented in at least three distinct neighbourhoods (urban, peri-urban, or rural) located in at least three different EU Member States or Associated Countries. Key filtering criteria for initial screening include a clear focus on sufficiency measures, resource demand reduction in the built environment, a strong research and innovation component, and the ability to conduct multi-country pilot projects. This topic is part of the New European Bauhaus (NEB) initiative within the Horizon Europe Work Programme 2025, indicating it is a recurring program, but this specific call is for the 2025 funding cycle.

Funding

Up to 4000000.00 EUR

Deadline

Nov. 12, 2025, midnight

Details

NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)

PAR-24-301

Programme: National Institutes of Health (NIH)

The core objective of this grant is to support the continued operation, maintenance, and enhancement of mature bioinformatics resources. These resources must be crucial for the research community utilizing animal models of embryonic developmental processes, with an emphasis on wide dissemination and interoperability. - Target recipient type and size: Organizations such as Higher Education Institutions, Nonprofits, For-Profit Organizations, and various Government entities that currently maintain established, mature bioinformatics resources. Organizational size is not defined by employee count, but implies entities with significant scientific and technical capacity. - SECTOR-SPECIFIC: This grant is sector-specific, focusing on bioinformatics resources within biomedical research, particularly developmental biology and congenital anomalies. - Geographic scope and any location requirements: The lead applicant organization must be based in the United States. While foreign components (e.g., international collaborators) are allowed within a U.S. organization's application, non-U.S. entities are not eligible to apply as the primary applicant. - Key filtering criteria for initial grant screening: The project must involve a mature, existing bioinformatics resource, not initial research and development or proof-of-concept. It must pertain to animal models of embryonic developmental processes, human/animal development, or structural congenital anomalies. Clinical trials are not allowed. - Grant frequency and program context: This is a recurring grant opportunity, being a reissue of a previous program (PAR-20-126). It is part of the National Institutes of Health's (NIH) ongoing efforts to support critical bioinformatics infrastructure for large-scale biological data.

Funding

Up to 1750000.00 USD

Deadline

Sept. 25, 2027, 5 p.m.

Details

Fighting against anti-Muslim hatred

CERV-2025-EQUAL-ANTIMUSLIM

Programme: Citizens, Equality, Rights and Value Programme (CERV)

This grant, titled 'Fighting against anti-Muslim hatred,' is a specific priority within the broader 'Call for proposals to promote equality and to fight against racism, xenophobia and all other forms of discrimination' under the Citizens, Equality, Rights and Value Programme (CERV). Its core objective is to support EU action grants aimed at combating anti-Muslim hatred, discrimination, and racism. It is a SECTOR-SPECIFIC grant, focusing on social issues related to equality and non-discrimination. The exact target recipient type and size, as well as the specific geographic scope and eligible countries, are not detailed in the provided grant information but are referred to external call documents. This grant is part of the recurring CERV program (2021-2027), indicating ongoing opportunities in this area.

Funding

Up to None EUR

Deadline

Oct. 23, 2025, 3 p.m.

Details

HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)

PAR-25-154

Programme: NIH HEAL Initiative

The core objective of this grant is to identify new druggable targets for pain within the understudied druggable proteome. It aims to support pilot projects that generate preliminary data and tools for these targets, ultimately contributing to novel medications for pain and the opioid addiction cycle.

Explicit identification of target recipient type: This grant targets a broad range of research-focused entities, including higher education institutions, non-profits, for-profit organizations, and various governmental bodies with scientific research capacity.
Size: Not explicitly defined by employee count, but the 'R03 Small Grant Program' designation indicates a focus on projects of limited scope and budget.
SECTOR-SPECIFIC: This grant is highly sector-specific, focusing on HEALTHCARE, particularly biomedical research, pain management, and opioid addiction.
Geographic scope: Applicant organizations must be based in the United States. While foreign components (collaborators) are allowed, the primary applying entity must be U.S.-based.
Key filtering criteria for initial grant screening:
The project must focus on one or more of the explicitly listed understudied proteins within the NOFO.
The project must not involve clinical trials or clinical drug development studies.
The research must be related to pain and/or pain management.
The applicant organization must be U.S.-based.
Grant frequency: This is a recurring funding opportunity, noted as a reissue of a previous program (PAR-24-197).
Program context: This grant is part of the broader NIH HEAL Initiative (Helping to End Addiction Long-term), addressing the national opioid public health crisis.

Funding

Up to 100000.00 USD

Deadline

July 16, 2026, 10 p.m.

Details

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)

PAR-24-063

Programme: Blueprint Neurotherapeutics Network (BPN)

The core objective of this grant is to advance small molecule drug discovery and development projects, specifically for disorders of the nervous system, towards clinical application. It targets United States small business concerns (SBCs) that have projects in either the Discovery (early-stage optimization) or Development (pre-clinical to Phase I clinical testing) phase. - Single, clear statement of grant's core objective: To facilitate the discovery and development of small molecule neurotherapeutics from pre-clinical stages through Phase I clinical trials by providing funding, resources, and expert support to small business concerns. - Explicit identification of target recipient type and size: Small Business Concerns (SBCs) with not more than 500 employees. - MUST state if grant is 'SECTOR-SPECIFIC' or 'SECTOR-AGNOSTIC': SECTOR-SPECIFIC (Neuroscience, Small Molecule Drug Development). - Geographic scope and any location requirements: Organizations must be located in the United States and operate primarily within the US. - Key filtering criteria for initial grant screening: - Must be a US-based small business concern. - Focus on small molecule drug discovery and development for nervous system disorders. - Project must be in Discovery or Development stage (pre-clinical to Phase I clinical trials). - Projects focusing on biologics, biotechnology products, devices, basic research, or beyond Phase I clinical testing are not eligible. - Grant frequency and program context: This is a reissue (PAR-24-063) and offers recurring application due dates, indicating it is a recurring opportunity within the Blueprint Neurotherapeutics Network (BPN) program.

Funding

Up to 5500000.00 USD

Deadline

July 15, 2026, 5 p.m.

Details

Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)

PAR-24-098

Programme: Small Business Innovation Research (SBIR) Program

This grant, PAR-24-098, aims to support the rigorous analytical validation of methods used for measuring biomarkers relevant to neurological and neuromuscular disorders. The goal is to prepare these biomarkers for use in clinical trials or clinical practice.

Target Recipient Type and Size: SME (small business concerns, generally with less than 500 employees).
SECTOR-SPECIFIC: Healthcare, specifically neurological and neuromuscular disorders.
Geographic Scope: Applicants must be U.S.-based organizations.
Key Filtering Criteria: Focus on analytical validation of biomarkers for neurological/neuromuscular disorders, U.S. small business, and experience in biomarker research.
Grant Frequency and Program Context: This is a recurring funding opportunity (reissue of PAR-21-057) under the NIH Small Business Innovation Research (SBIR) program, designed to bridge the gap between biomarker discovery and clinical application.

Funding

Up to 1500000.00 USD

Deadline

June 22, 2026, 5 p.m.

Details

Partners for Fish and Wildlife Program

Programme: U.S. Fish & Wildlife Service

The core objective of the Partners for Fish and Wildlife Program is to provide technical and financial assistance to private landowners for restoring, enhancing, and managing fish and wildlife habitats on their land across the United States. This program aims to conserve and improve wildlife habitat by partnering with a broad range of private entities. - Target recipient type and size: Private landowners, managers, tribes, corporations, schools, non-profits, farmers, ranchers, forest landowners, recreational landowners, local governments, and universities. - SECTOR-SPECIFIC: Environmental conservation, land management, agriculture, and forestry. - Geographic scope: United States (all 50 states and territories). - Key filtering criteria for initial grant screening: Private land ownership, interest in wildlife habitat improvement, willingness to commit to a minimum 10-year project duration. - Grant frequency and program context: This is an ongoing, recurring program established since 1987, reauthorized by the Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025.

Funding

Up to 0.00 USD

Deadline

March 8, 2029, 4:59 a.m.

Details

You can filter by below criteria

Grants